Matinas BioPharma to Present at 29th Annual ROTH Conference
BEDMINSTER, N.J., March 10, 2017 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE MKT:MTNB), clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications, today announced that Jerome D. Jabbour …